Diagnostic Products Corporation Schedules Conference Call to Discuss Fourth Quarter and Year End 2005 Results
02 Februar 2006 - 7:30PM
Business Wire
Diagnostic Products Corporation (NYSE: DP) announced today that it
has scheduled a conference call to discuss the Company's financial
results of its fourth quarter and year end 2005 on Friday, February
10, 2006, at 11:30 a.m. Eastern standard time (8:30 a.m. PST). The
Company plans to release its financial results before the market
opens on Friday. If you are interested in participating in the
call, please call 800-260-6066 or 913-312-9312 on the day of the
conference, at least ten minutes prior to the conference in order
for the operator to tie you into the call. The operator will ask
you to identify the call with the company name Diagnostic Products
Corporation-Jim Brill. An "instant replay" of the call will be
available until February 21. If you would like to take advantage of
this special service, you can access it via 888-203-1112 and the
code: "7682342." It usually takes two hours following the
conference to set up the recording. About Diagnostic Products
Corporation Diagnostic Products Corporation, founded in 1971, is a
global leader dedicated to immunodiagnostics. DPC's product menu
includes over 75 immunoassays and more than 375 specific allergens
and allergy panels. In addition, DPC addresses the chemistry and
laboratory automation testing needs of its customers through
partnerships with manufacturers of chemistry systems and reagents.
The combined chemistry and immunoassay menu is one of the largest
and most diversified available, covering most laboratory tests
requested. DPC also designs and manufactures automated laboratory
instrumentation, which provides fast, accurate results while
reducing labor and reagent costs. DPC sells its products to
hospitals, clinics and laboratories in more than 100 countries.
Additional Company information can be found on DPC's website at
www.dpcweb.com. Except for the historical information contained
herein, this press release contains forward-looking statements that
involve risks and uncertainties that could cause actual results to
differ materially. These factors include governmental or other
action relating to the Company's Chinese affiliate; the rate of
customer demand for the Company's products; the Company's ability
to successfully market new and existing products; its dependence on
certain suppliers; domestic and foreign government regulation; its
ability to keep abreast of technological innovations and to
translate them into new products; competition; political and
economic instability in certain markets including the movements of
foreign currencies relative to the dollar; and other risks and
uncertainties disclosed from time to time in the Company's SEC
reports and filings.
Diagnostic Products (NYSE:DP)
Historical Stock Chart
Von Apr 2024 bis Mai 2024
Diagnostic Products (NYSE:DP)
Historical Stock Chart
Von Mai 2023 bis Mai 2024
Echtzeit-Nachrichten über Diagnostic Products (New York Börse): 0 Nachrichtenartikel
Weitere Diagnostic Products Corporation News-Artikel